PubMed:33149259 / 178-357 JSONTXT

{"project":"mondo_disease","denotations":[{"id":"T4","span":{"begin":83,"end":86},"obj":"Disease"},{"id":"T5","span":{"begin":116,"end":119},"obj":"Disease"},{"id":"T6","span":{"begin":164,"end":167},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0008315"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0008315"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0008315"}],"text":"However, their lack of specificity to distinguish benign prostate pathologies from PCa, or indolent from aggressive PCa have prompted the study of new non-invasive PCa biomarkers."}

{"project":"HP-phenotype","denotations":[{"id":"T5","span":{"begin":83,"end":86},"obj":"Phenotype"},{"id":"T6","span":{"begin":105,"end":115},"obj":"Phenotype"},{"id":"T7","span":{"begin":116,"end":119},"obj":"Phenotype"},{"id":"T8","span":{"begin":164,"end":167},"obj":"Phenotype"}],"attributes":[{"id":"A5","pred":"hp_id","subj":"T5","obj":"HP:0012125"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"HP:0000718"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"HP:0012125"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"HP:0012125"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"However, their lack of specificity to distinguish benign prostate pathologies from PCa, or indolent from aggressive PCa have prompted the study of new non-invasive PCa biomarkers."}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T4","span":{"begin":83,"end":86},"obj":"Phenotype"},{"id":"T5","span":{"begin":116,"end":119},"obj":"Phenotype"},{"id":"T6","span":{"begin":164,"end":167},"obj":"Phenotype"}],"attributes":[{"id":"A4","pred":"hp_id","subj":"T4","obj":"HP:0012125"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"HP:0012125"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"HP:0012125"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"However, their lack of specificity to distinguish benign prostate pathologies from PCa, or indolent from aggressive PCa have prompted the study of new non-invasive PCa biomarkers."}

{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T4","span":{"begin":57,"end":65},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0002367"}],"text":"However, their lack of specificity to distinguish benign prostate pathologies from PCa, or indolent from aggressive PCa have prompted the study of new non-invasive PCa biomarkers."}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T7","span":{"begin":83,"end":86},"obj":"Disease"},{"id":"T9","span":{"begin":116,"end":119},"obj":"Disease"},{"id":"T11","span":{"begin":164,"end":167},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"MONDO:0005159"},{"id":"A8","pred":"mondo_id","subj":"T7","obj":"MONDO:0008315"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"MONDO:0005159"},{"id":"A10","pred":"mondo_id","subj":"T9","obj":"MONDO:0008315"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"MONDO:0005159"},{"id":"A12","pred":"mondo_id","subj":"T11","obj":"MONDO:0008315"}],"namespaces":[{"prefix":"MONDO","uri":"http://purl.obolibrary.org/obo/MONDO_"}],"text":"However, their lack of specificity to distinguish benign prostate pathologies from PCa, or indolent from aggressive PCa have prompted the study of new non-invasive PCa biomarkers."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T3","span":{"begin":0,"end":179},"obj":"Sentence"}],"text":"However, their lack of specificity to distinguish benign prostate pathologies from PCa, or indolent from aggressive PCa have prompted the study of new non-invasive PCa biomarkers."}

{"project":"GlyCosmos15-FMA","denotations":[{"id":"T5","span":{"begin":57,"end":65},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"db_id","subj":"T5","obj":"FMA:9600"}],"namespaces":[{"prefix":"FMA","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"However, their lack of specificity to distinguish benign prostate pathologies from PCa, or indolent from aggressive PCa have prompted the study of new non-invasive PCa biomarkers."}

{"project":"GlyCosmos15-MAT","denotations":[{"id":"T4","span":{"begin":57,"end":65},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"mat_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MAT_0000078"}],"text":"However, their lack of specificity to distinguish benign prostate pathologies from PCa, or indolent from aggressive PCa have prompted the study of new non-invasive PCa biomarkers."}

{"project":"Anatomy-MAT","denotations":[{"id":"T4","span":{"begin":57,"end":65},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"mat_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MAT_0000078"}],"text":"However, their lack of specificity to distinguish benign prostate pathologies from PCa, or indolent from aggressive PCa have prompted the study of new non-invasive PCa biomarkers."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T4","span":{"begin":57,"end":65},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0002367"}],"text":"However, their lack of specificity to distinguish benign prostate pathologies from PCa, or indolent from aggressive PCa have prompted the study of new non-invasive PCa biomarkers."}